4//SEC Filing
Cowan Chad 4
Accession 0002039294-25-000004
CIK 0001850119other
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 4:56 PM ET
Size
6.2 KB
Accession
0002039294-25-000004
Insider Transaction Report
Form 4
Cowan Chad
Chief Scientific Officer
Transactions
- Award
Common Stock
2025-09-18+762,543→ 992,489 total
Holdings
- 10,697(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 50% on October 1, 2026, with the remaining 50% vesting on October 1, 2027, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
- [F2]Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
Documents
Issuer
Century Therapeutics, Inc.
CIK 0001850119
Entity typeother
Related Parties
1- filerCIK 0002039294
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 4:56 PM ET
- Size
- 6.2 KB